Edinburgh Imaging's current multiple sclerosis projects.
Current projects
Title |
Description |
CCMR1 |
- A double-blind, randomised placebo-controlled study of the safety & tolerability of a retinoid-X receptor agonist’s ability to promote remyelination in people with relapsing-remitting multiple sclerosis already on disease-modifying therapy: a phase 2a trial.
|
Future MS |
- To develop predictive tools for focal neuroinflammatory disease activity over 12-months based on baseline clinical, laboratory, & genomic assessment.
|
Future MS 2 |
- To investigate questions MS patients commonly ask their doctors about, including invisible disability symptoms like pain and fatigue.
|